Skip to main content
Premium Trial:

Request an Annual Quote

NaPro to Apply Gene Editing Technology in Wheat Genome Project

NEW YORK, July 23 - NaPro BioTherapeutics has entered into a research agreement with North Dakota State University to apply its gene editing technology in the wheat genome project, the company said today.

 

The company said it will work with the university researchers to make single base-pair changes in wheat genes to improve crop traits. The work will help NaPro further develop this technology for agro-genomics applications, the company said.

 

The organizations did not disclose the financial terms of the agreement.

 

NaPro's gene editing technology uses oligonucleotides to locate, label, isolate, and modify a single base pair in an organism's gene, the company said. It is does not use foreign genetic material such as transgenes or plasmid vectors.  The company, based in   Boulder, Colo, develops natural product biopharmaceuticals, and develops and licenses genomics technologies for agriculture, pharmacogenomics, diagnostics, and therapeutics.

 

 

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.